Biotech news
Pharma
While the political will exists for the introduction of the Unified Patent Court next year, much more still needs to be done, according to Adam Cooke, a partner in DLA Piper's IP and technology group. 5 March 2014
Americas
Apexigen uses antibodies derived from rabbits to develop therapies for diseases that are difficult to treat. LSIPR found out how it protects its novel technologies. 28 February 2014
Biotech
Second and further medical use claims provide companies and patent lawyers with interesting opportunities, as Caroline Pallard explains. 19 February 2014
Biotech
Baker & McKenzie LLP has added to its IP team with the appointment of Hiroshi Sheraton as partner in its London office. 17 February 2014
Americas
In a global league, Canada’s biotech industry would be respectably mid table. LSIPR talks to Andrew Casey, president of industry association BIOTECanada, about how the organisation is trying to take it to the next level. 3 February 2014
Americas
The US Supreme Court has ruled that when licensees seek a declaratory judgement of non-infringement, the patentee bears the burden of proof to show infringement. 22 January 2014
Biotech
UK law firm Potter Clarkson LLP has made changes to its team with the appointment of two senior managers. 15 January 2014
Americas
IP law firm Sterne Kessler Goldstein & Fox PLLC has announced the election of three new directors to its life sciences team. 14 January 2014
Americas
Stem cells are seen by many as the great hope for medical research in the years to come. LSIPR spoke to Nicholas Seay, chief technology officer at Cellular Dynamics, about the importance of IP in this field. 13 January 2014
Americas
General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion. 13 January 2014